
Rubius Therapeutics RUBY
Annual report 2022
added 02-27-2023
Rubius Therapeutics EBITDA per Share 2011-2026 | RUBY
Annual EBITDA per Share Rubius Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.91 | -2.12 | -1.99 | -2.12 | -2.3 | -0.926 | -1.26 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.926 | -2.3 | -1.8 |
Quarterly EBITDA per Share Rubius Therapeutics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -0.62 | -0.44 | -0.55 | - | -0.51 | -0.52 | -0.48 | -0.49 | -0.43 | -0.42 | -0.59 | -0.57 | -0.58 | -0.51 | -0.44 | -0.37 | -0.43 | -2.28 | -1.72 | -1.17 | -1.45 | -1.13 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -0.37 | -2.28 | -0.748 |
EBITDA per Share of other stocks in the Biotechnology industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-15.2 | - | 2.43 % | $ 254 M | ||
|
AgeX Therapeutics
AGE
|
-2.35 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
0.08 | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
-0.09 | - | -18.52 % | $ 27.3 M | ||
|
Esperion Therapeutics
ESPR
|
0.29 | $ 3.13 | 0.55 % | $ 651 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
6.75 | - | - | $ 40.3 B | ||
|
Exelixis
EXEL
|
3.32 | $ 46.48 | 4.64 % | $ 12.6 B | ||
|
Fortress Biotech
FBIO
|
-2.5 | $ 2.5 | 1.63 % | $ 69.8 M | ||
|
Biophytis SA
BPTS
|
-0.23 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
-2.24 | - | 2.54 % | $ 160 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.22 | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
-23.7 | - | - | $ 269 M | ||
|
Galapagos NV
GLPG
|
-2.53 | $ 28.79 | 1.41 % | $ 2.69 B | ||
|
Genmab A/S
GMAB
|
10.4 | $ 27.79 | 0.92 % | $ 17.1 B | ||
|
Genprex
GNPX
|
-264 | $ 0.9 | 1.12 % | $ 839 K | ||
|
Grifols, S.A.
GRFS
|
0.87 | $ 8.33 | 0.73 % | $ 6.83 B | ||
|
InflaRx N.V.
IFRX
|
-1.49 | $ 2.51 | 27.51 % | $ 152 M | ||
|
Ionis Pharmaceuticals
IONS
|
-1.28 | $ 76.27 | 1.36 % | $ 12.2 B | ||
|
BioNTech SE
BNTX
|
62.6 | $ 95.08 | -0.44 % | $ 27.2 B | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.69 | - | - | - | ||
|
Kamada Ltd.
KMDA
|
-0.02 | $ 8.28 | 0.85 % | $ 260 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
-2.84 | - | - | $ 231 M | ||
|
Kymera Therapeutics
KYMR
|
-4.04 | $ 85.67 | 3.58 % | $ 7.24 B | ||
|
Kazia Therapeutics Limited
KZIA
|
-1.35 | $ 13.28 | -1.26 % | $ 1.76 B | ||
|
INmune Bio
INMB
|
-1.91 | $ 1.54 | - | $ 38.1 M | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
0.69 | $ 232.25 | -0.02 % | $ 4.25 B | ||
|
Liquidia Corporation
LQDA
|
-0.58 | $ 41.83 | 4.24 % | $ 3.6 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
1.4 | $ 22.89 | 2.42 % | $ 3.79 B | ||
|
Mirum Pharmaceuticals
MIRM
|
0.04 | $ 108.2 | 2.26 % | $ 5.43 B | ||
|
Advaxis
ADXS
|
-5.96 | - | -9.65 % | $ 45.9 M | ||
|
MannKind Corporation
MNKD
|
0.17 | $ 3.84 | 34.27 % | $ 1.17 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-6.03 | $ 3.51 | 0.29 % | $ 5.78 M | ||
|
Aeterna Zentaris
AEZS
|
-0.08 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-6.7 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
-2.22 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.36 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
-3.89 | - | 1.93 % | $ 17.4 M | ||
|
Akero Therapeutics
AKRO
|
-4.25 | - | - | $ 3.67 B | ||
|
Aptose Biosciences
APTO
|
0.01 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-0.92 | - | -39.0 % | $ 4.57 M | ||
|
Akouos
AKUS
|
-2.45 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
-6.41 | - | -0.23 % | $ 916 M | ||
|
Allakos
ALLK
|
-2.19 | - | - | $ 28.6 M | ||
|
AlloVir
ALVR
|
-3.02 | - | 4.14 % | $ 49.1 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-0.09 | $ 23.68 | 1.09 % | $ 3.01 B | ||
|
Nanobiotix S.A.
NBTX
|
-1.49 | $ 41.17 | 18.39 % | $ 286 B | ||
|
Allena Pharmaceuticals
ALNA
|
-0.696 | - | 3.16 % | $ 1.9 M | ||
|
Ampio Pharmaceuticals
AMPE
|
0.15 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
-3.2 | - | - | $ 10.1 M |